Iron control of the Vibrio fischeri luminescence system in Escherichia coli.
Iron influences luminescence in Vibrio fischeri; cultures iron-restricted for growth rate induce luminescence at a lower optical density (OD) than faster growing, iron-replete cultures. An iron restriction effect analogous to that in V. fischeri (slower growth, induction of luminescence at a lower OD) was established using Escherichia coli tonB and tonB+ strains transformed with recombinant plasmids containing the V. fischeri lux genes (luxR luxICDABEG) and grown in the presence and absence of the iron chelator ethylenediamine-di(o-hydroxylphenyl acetic acid) (EDDHA). This permitted the mechanism of iron control of luminescence to be examined. A fur mutant and its parent strain containing the intact lux genes exhibited no difference in the OD at induction of luminescence. Therefore, an iron-binding repressor protein apparently is not involved in iron control of luminescence. Furthermore, in the tonB and in tonB+ strains containing lux plasmids with Mu dI(lacZ) fusions in luxR, levels of beta-galactosidase activity (expression from the luxR promoter) and luciferase activity (expression from the luxICDABEG promoter) both increased by a similar amount (8-9 fold each for tonB, 2-3 fold each for tonB+) in the presence of EDDHA. Similar results were obtained with the luxR gene present on a complementing plasmid. The previously identified regulatory factors that control the lux system (autoinducer-LuxR protein, cyclic AMP-cAMP receptor protein) differentially control expression from the luxR and luxICDABEG promoters, increasing expression from one while decreasing expression from the other. Consequently, these results suggest that the effect of iron on the V. fischeri luminescence system is indirect.
Dunlap
P V
PV
Biology Department, Redfield Laboratory, Woods Hole Oceanographic Institution, MA 02543.
D001426:Bacterial Proteins / Q000187:drug effects / Q000235:genetics / Q000494:pharmacology; D004926:Escherichia coli / Q000378:metabolism; D005029:Ethylenediamines / Q000494:pharmacology; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects*; D007501:Iron / Q000494:pharmacology*; D008156:Luciferases / Q000032:analysis; D008163:Luminescent Measurements; D008164:Luminescent Proteins / Q000187:drug effects / Q000235:genetics; D011401:Promoter Regions, Genetic; D012097:Repressor Proteins / Q000494:pharmacology; D014733:Vibrio / Q000187:drug effects / Q000201:enzymology / Q000235:genetics*; D001616:beta-Galactosidase / Q000032:analysis
D001426:Bacterial Proteins; D005029:Ethylenediamines; D008164:Luminescent Proteins; D012097:Repressor Proteins; C068477:ferric uptake regulating proteins, bacterial; C011813:ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid); D007501:Iron; D008156:Luciferases; D001616:beta-Galactosidase